Engineered microparticles for macromolecule delivery

Abstract

A method for making a modified release composition, comprising: selecting a desired active agent and polymer matrix for formulating into a modified release composition; assessing degradation effect on release of the active agent from the composition including plotting polymer molecular weight (M wr ) at onset of active agent release vs. active agent molecular weight (M wA ); predicting performance of multiple potential formulations for the composition based on the degradation assessment and average polymer matrix initial molecular weight (M wo ) to define a library of building blocks; determining the optimal ratio of the building blocks to satisfy a specified release profile; and making a modified release composition based on the optimal ratio determination.

What is claimed is: 
     
         1 . A computer-implemented method comprising:
 receiving, by a processor, a dissolution rate for a formulation containing an active agent;   assessing, by the processor, dissolution rates for sample formulations containing at least one hydrolys able polymer and the active agent based on properties of each of the at least one hydrolys able polymer and properties of the active agent; and   generating, by the processor, a formulation containing the at least one hydrolys able polymer and the active agent, wherein the formulation has a dissolution rate corresponding to the dissolution rate.   
     
     
         2 . The method of  claim 1 , wherein the properties for each of at least one hydrolysable polymer are selected from the group consisting of initial molecular weights (Mwo) and polymer degradation rates (kCw). 
     
     
         3 . The method of  claim 1 , wherein the step of identifying formulations comprises:
 performing, by the processor, non-linear optimization on one or more formulations to determine the percent total composition of each of the at least one hydrolysable polymer in each formulation;   eliminating, by the processor, each formulation having the percent total composition of less than 1 percent for at each least one hydrolysable polymer;   repeating the step of performing non-linear optimization and eliminating each formulation until a percent change of greater than 5 percent is reached or one formulation remains.   
     
     
         4 . The method of  claim 1 , wherein the formulation defines a composition that is a sustained release pharmaceutical composition. 
     
     
         5 . The method of  claim 1 , wherein the active agent is a bioactive agent or a therapeutic agent. 
     
     
         6 . The method of  claim 1 , wherein each at least one hydrolysable polymer is selected from the group consisting of poly(glycolic acid), poly(lactic acid), poly(lactide-co-glycolide), polyanhydride, poly(α-hydroxy ester), poly(β-hydroxy ester), poly(ortho ester), and mixtures thereof. 
     
     
         7 . The method of  claim 1 , wherein the formulation defines a medicament. 
     
     
         8 . The method of  claim 7 , wherein the medicament comprises at least two populations of microparticles. 
     
     
         9 . The method of  claim 7 , wherein the medicament is selected from the group consisting of matrix tablets, enteric coated tablets, single and double coated tablets, capsules, minitablets, caplets, coated beads, granules, spheroids, pellets, microparticles, suspensions, topicals, injectables, inhalable compositions, and implants. 
     
     
         10 . The method of  claim 1 , further comprising making a composition based on the formulation. 
     
     
         11 . The method of  claim 1 , wherein the properties of the active agent are selected from an agent's molecular weight (MwA), aqueous solubility, isoelectric point, and combinations thereof. 
     
     
         12 . The method of  claim 1 , wherein predicting a dissolution rate further comprises determining a mean time for pore formation (τ) based on the physical properties of each at least one hydrolysable polymer. 
     
     
         13 . The method of  claim 12 , further comprising determining a variance (σ 2 ) in induction time distribution for pore formation (ε(t)). 
     
     
         14 . The method of  claim 13 , wherein determining the variance (σ 2 ) further comprises determining a distribution of polymer degradation rates (kC w (n)) attributed to crystallinity of each at least one hydrolysable polymer. 
     
     
         15 . The method of  claim 1 , wherein predicting the dissolution rate further comprises determining a diffusivity of the active agent (D) from each at least one hydrolysable polymer. 
     
     
         16 . The method of  claim 1 , wherein predicting a dissolution rate further comprises determining a molecular weight at release (Mwr) for each at least one hydrolysable polymer based on the physical properties of the at least one active agent. 
     
     
         17 . The method of  claim 13 , wherein the molecular weight at release (Mwr) is determined based on a molecular weight of the at least active agent (MwA) encapsulated by each at least one hydrolysable polymer.